Anja Lautem
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic marker.
Journal: Clinical and translational medicine
Published: October 30, 2023
The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients.
Journal: Pathogens (Basel, Switzerland)
Published: March 10, 2023
Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant Recipients.
Journal: Pathogens (Basel, Switzerland)
Published: December 10, 2021
Hepatitis E Is a Rare Finding in Liver Transplant Patients With Chronic Elevated Liver Enzymes and Biopsy-Proven Acute Rejection.
Journal: Transplantation proceedings
Published: July 15, 2019
Cirrhosis risk score of the donor organ predicts early fibrosis progression after liver transplantation.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: March 10, 2019
Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
Journal: Oncology reports
Published: July 02, 2018
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: November 17, 2017
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
Journal: International journal of oncology
Published: November 20, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026